This phenotypic dichotomy, coupled with reports of lethal vascular complications (sudden cardiac death in a LZTR1-variant carrier with COVID-19 comorbidity [22]), strongly implicates RAS/MAPK hyperactivation in endothelial dysregulation and aberrant vasculogenesis. This evidence concerns the gene LZTR1 and COVID-19.